| 000 | 01368 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513045930.0 | ||
| 264 | 0 | _c19950322 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0091-3057 | ||
| 024 | 7 |
_a10.1016/0091-3057(94)90062-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlick, D W | |
| 245 | 0 | 0 |
_aPrimate performance decrements following acute soman exposure: failure of chemical countermeasures. _h[electronic resource] |
| 260 |
_bPharmacology, biochemistry, and behavior _cNov 1994 |
||
| 300 |
_a503-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aCholinesterase Reactivators _xpharmacology |
| 650 | 0 | 4 |
_aCholinesterases _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPralidoxime Compounds _xpharmacology |
| 650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
| 650 | 0 | 4 |
_aPyridostigmine Bromide _xpharmacology |
| 650 | 0 | 4 |
_aSoman _xantagonists & inhibitors |
| 700 | 1 | _aMurphy, M R | |
| 700 | 1 | _aBrown, G C | |
| 700 | 1 | _aHartgraves, S L | |
| 773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 49 _gno. 3 _gp. 503-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0091-3057(94)90062-0 _zAvailable from publisher's website |
| 999 |
_c7862037 _d7862037 |
||